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Highlights  
 
 We developed a clustering methodology to deal with Arterial Pressure Waveform (APW) 
parameters. 
 A new non-invasive device is being evaluated. 
 We collect a database of 116 subjects. 
 This study compares different methods used in the APW analysis toward cardiovascular 
diseases. 
 It is possible to assess potential cardiovascular risk in healthy subjects using cluster analysis. 
*Highlights (for review)
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Cardiovascular risk analysis by means of pulse morphology
and clustering methodologies
Vaˆnia G. Almeida1 , J. Borba1, H. Catarina Pereira1,2, Taˆnia Pereira1, Carlos Correia1,
Mariano Peˆgo3 and Joa˜o Cardoso1
1 Physics Department, Electronics and Instrumentation Group, University of Coimbra
2 Intelligent Sensing Anywhere
3 Cardiology Department, Hospital and University Coimbra Center
Abstract
The purpose of this study was the development of a clustering methodology to deal with
Arterial Pressure Waveform (APW) parameters to be used in the cardiovascular risk
assessment. One hundred sixteen subjects were monitored and divided in two groups.
The first one (23 hypertensive subjects) was analysed using APW and biochemical
parameters, while the remaining 93 healthy subjects were only evaluated through APW
parameters. The Expectation Maximization (EM) and k-means algorithms were used
in the cluster analysis, and the risk scores (the Framingham Risk Score (FRS), the
Systematic COronary Risk Evaluation Project (SCORE), the Assessing cardiovascular
risk using Scottish Intercollegiate Guidelines Network guidelines (ASSIGN) and
the PROspective Cardiovascular Mu¨nster (PROCAM)), commonly used in clinical
practice were selected to the cluster risk validation. The result from the clustering
risk analysis showed a very significant correlation with ASSIGN (r = 0.582, p <
0.01) and a significant correlation with FRS (r = 0.458, p < 0.05). The results
from the comparison of both groups also allowed to identify the cluster with higher
cardiovascular risk in the healthy group. These results give new insights to explore this
methodology in future scoring trials.
Email address: vaniagalmeida@lei.fis.uc.pt (Vaˆnia G. Almeida1)
Preprint submitted to Elsevier June 12, 2014
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1. Introduction1
The atherosclerotic Cardiovascular Disease (CVD) is the most common cause of2
death worldwide, resulting from the combination of several risk factors [1]. The3
international guidelines [2, 3] consider that individuals with established CVD should4
be the first priority for preventive measures application. The concern in changing the5
current healthcare paradigm, from reactive towards preventive care, aims at identify6
individuals for risk in early stages of disease development, and then, direct more7
efforts and attention to the risk factors modification [4, 5]. Fortunately, this is an8
emergent tendency that can be addressed using the traditional risk scores, but also9
using innovative predictive algorithms.10
During the last years many risk estimation systems have been developed in order11
to assist clinicians in the risk assessment, and in the individual chances prediction, for12
CVD development. The major challenges of these tools are the capabilities to: (1)13
identify high risk individuals, (2) weight the individual effects of all risk factors, (3)14
stratify or organize who needs lifestyle advice or medical therapy, and finally (4) avoid15
overmedicalization of individuals at low risk [6]. Taking this challenges into account16
several risk factors were identified, by their association with an increased risk for CVD17
development. CVD risk assessment tools differ from each other on the selected risk18
factors, the disease for what they were designed (Coronary Heart Disease (CHD),19
heart failure, etc.), the selected event type, the considered period of time (long or20
short term) and the cohort location. The most popular are: Framingham Risk Score21
(FRS), PROspective CArdiovascular Mu¨nster (PROCAM), ASsessing cardiovascular22
risk using Scottish Intercollegiate Guidelines Network (ASSIGN) and Systematic23
COronary Risk Evaluation project (SCORE).24
These tools are important to help physicians in their daily practice. However,25
2
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its application in different populations remains a topic concerning attention. The26
research needs to be directed at refining the accuracy of prediction models and, most27
importantly, examining ways of turning them into effective clinical tools. Several risk28
prediction models for cardiovascular disease are available today and their head to head29
comparison and application in different populations would benefit from standardized30
reporting and formal, consistent statistical comparisons. The work presented by [7]31
reinforces this statement. The limitations of the comparison of different methods is32
associated to missing information, which makes difficult to reach robu t conclusions33
about the best model or the ranking of models’ performance. And, additionally most34
studies did not statistically compare the models that were examined. The inclusion35
of standardized reporting of discrimination, calibration, and reclassification metrics36
with formal statistical comparisons would contribute to the successful application of37
different risk scores in distinct populations.38
The trends for the risk overestimation in low-risk populations and underestimation39
in high-risk groups have been successfully demonstrated by Cooney, et al. [6]. It40
is known that an examination of 5 % SCORE can equate to a 10− 25 % FRS risk,41
depending on which of the several FRS functions is selected [3]. Haq, et al. [8]42
studied several methods for risk estimation (FRS, PROCAM, Dundee, and British43
regional heart-BRHS) and the results demonstrated a close agreement between all44
these, regarding average risk and showed moderate agreement for estimation among45
individuals. Finally, it was also concluded that FRS function is acceptably accurate in46
northern European populations.47
The arterial stiffness measurement currently assumes an increasing role in clinical48
assessment due to its predictive value in cardiovascular events in patients with various49
risk levels, such as it was demonstrated by several studies [9, 10, 11, 12]. There are50
several advantages of using non-invasive methods over invasive measurements, e.g., the51
potential use in follow-up strategies in populations without symptomatic CVD, such as52
3
Page 5 of 27
Ac
ce
pte
d M
an
us
cri
pt
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
children or young adults. Furthermore, non-invasive tools can be essential to the CVD53
assessment in addition to the established risk factors in populations at high risk aiming54
the prevention of coronary vascular diseases. Inferences about CVD progressive55
development can be assessed by the analysis of the mechanical properties of arteries56
through a variety of indices based on the Pulse Wave Analysis (PWA) [13, 14]. The57
analysis is based on the identification of the key features in the arterial pressure wave58
profile, such as Systolic Wave Transit Time (SWTT), Reflected Wave Transit Time59
(RWTT) and dicrotic notch (evaluated by Left Ventricular Ejection Time (LVET)), and60
can include time or amplitude considerations, as well as variability based parameters61
[15]. The wave reflections are often addressed, in terms of the Augmentation Index62
(AIx), which expresses the ratio of the “augmented pressure” assigned to the reflected63
wave towards each overall pulse.64
Data mining techniques have attracted a great deal of attention due to their ability65
to extract implicit and potentially useful information from large volumes of data [16].66
Their feasible implementation in Computer-Aided Diagnosis (CAD) methodologies67
has given new insights in the development of innovative and effective decision support68
systems for CVD premature risk assessment [15, 17, 18, 19]. An interesting approach69
is the exploration of different classifiers, as it was proposed by Jovic et al. [20]. The70
electrocardiogram (ECG) classification problem was addressed using a combination of71
several features in the analysis of the Heart Rate Variability (HRV). Other approach72
presented by Tsipouras et al. [18] was based on the development of a fuzzy rule-73
based decision support system for CAD diagnosis. On the other hand, multi-classifiers74
should perform better in some situations, overcoming errors from single classifier75
analysis [21]. The incorporating of the prediction outcome of each one of the individual76
classifier was suggested, as a way to reduce the classification errors [22].77
On other hand, clustering analysis is another important branch of unsupervised78
learning that allows the arrangement of objects into groups (i.e., the clusters), wherein79
4
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the objects in the same cluster are more similar (in one or more characteristics), than80
those in different clusters [23]. There is a wide variety of clustering methodologies81
available in literature, essentially organized in three general classes [24]. The82
three types include parametric model-based, hierarchical and partitioning algorithms.83
Shah et al. [25] has proved the usefulness and feasibility of using clustering risk84
factors in the detection of CVD in youth, by the comparison with the Patholobiological85
Determinants of Atherosclerosis in Youth (PDAY) risk score. Other studies have also86
referred the role of clustering methodologies for CVD assessment, such as the work87
developed by Haseena et al. [26], where a fuzzy C-mean clustered probabilistic neural88
network for ECG beats discrimination was described. Clustering methodologies were89
also successful applied in other medical fields, such as in the identification of patterns90
in blood glucose measurements and regular insulin doses taken before meal time [27].91
Our aim is the development of a clustering methodology to deal with Arterial92
Pressure Waveform (APW) based parameters to cardiovascular risk assessment. The93
evaluation was performed through the strength of the relationships with traditional risk94
scores. In the current paper, Section 2 details the subjects and methods used during data95
analysis, including a quick and up-to-date literature survey on attempts for risk scores96
and clustering methods used. The results are presented and discussed in Sections 3 and97
4, respectively. Finally, in Section 5 some guidelines for further research are presented98
along with the main conclusions of the current work.99
2. Methodology100
2.1. Database101
The data used in this study were obtained from 116 subjects divided in two groups,102
as depicted in Figure 1(a). Data were collected with approval by the ethical committees103
of the Coimbra Hospital and University Centre (CHUC), Portugal, with informed104
consent. Hypertension was diagnosed when Systolic Blood Pressure (SBP) ≥ 140105
5
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mmHg and/or Diastolic Blood Pressure (DBP)≥ 90 mmHg, or if the patient was taking106
anti-hypertensive medication. Age, smoking habits, and familiar hypertensive history107
were recorded by structured questioning in accordance with the criteria used by each108
one of the scores. Current smoking was defined as having smoked the last cigarette less109
than 1 year before. Diabetes mellitus was considered for those subjects that presented a110
fasting blood sugar level >126 mg/dl, or current prescription of an oral hypoglycemic111
drug or insulin.112
Two groups of subjects were analysed: Group C and Group H. The group H113
inclusion criteria included diagnosed hypertension by a clinician and for Group C114
young subjects without any known cardiovascular complication.115
• Group H consists of 23 hypertensive subjects, 10 men and 13 women. Lipidic116
values were measured: the serum total cholesterol (Total-CH), the high density117
lipoprotein cholesterol (CH-HDL) and the triglyceride (TGL) levels. All subjects118
were tested at the same time of day to avoid any diurnal variations. Additionally,119
the APW parameters were also computed: SWTT, RWTT, SWA, LVET and AIx.120
• Group C consists of 93 young and healthy subjects between 18−30 years. The121
APW parameters were computed: SWTT, RWTT, SWA, LVET and AIx.122
2.2. PWA Measurements123
APWs were recorded at a sampling rate of 1 kHz with a single non-invasive PZ124
probe developed in a previous work [28], and shown in Figure 1(a) (main text). The125
probe is held in place by a neck collar specially developed for carotid measurements.126
The mechanical interface between the probe head and the sensing point also plays an127
important role on the data quality. The probe head is based on a mushroom-shaped PZ128
sensor that transmits the distension associated to the pressure wave in such a way that129
transversal and shear effects are suppressed and only radial applied forces are allowed.130
Accuracy tests were performed at a bench test, where 1.80% was the maximum Root131
6
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Figure 1: (a) Firstly, biochemical (CH-HDL - High density lipoprotein cholesterol
and Total-CH - Cholesterol Total), pressure values (SBP - Systolic Blood Pressure
and DBP - Diastolic Blood Pressure) and APW parameters (RWTT - Reflected Wave
Transit Time, RWA - Reflection Wave Amplitude, SWTT - Systolic Wave Transit
Time, LVET - Left Ventricular Ejection Time and AIx - Augmentation Index) were
collected. (b) Four risk scores were studied to use as the reference along this work,
namely: FRS - Framingham Risk Score, PROCAM - PROspective CArdiovascular
Mu¨nster risk score, ASSIGN - ASsessing cardiovascular risk to Scottish Intercollegiate
Guidelines Network and SCORE - Systematic COronary Risk Evaluation. (c) The
Expectation Maximization (EM) and k-means were the selected clustering algorithms,
and the Kruskal-Wallis Test was used to compare groups.
Mean Square Error (RMSE) introduced by the electronic circuits and by the mechanical132
interface.133
Some data concerning validation was also published in [29] comprising three134
sets of recordings for the carotid pressure waveform at left and right carotid arteries,135
under standardized conditions, in 20 volunteers by three trained operators. Inter and136
intra-operator differences were calculated being good indicators, similar to other data137
reported in literature for commercial devices [30].138
For each subject at least three consecutive measurements were performed. APW139
7
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parameters were tabulated for the set of pulses, considering each one of the subjects,140
after to the segmentation process. The PWA parameters, schematically represented in141
Figure 2, are related to amplitude and temporal characteristics of APW, namely:142
• Reflected Wave Transit Time (RWTT) is determined by the time interval between143
the foot of the carotid pressure waveform to the first inflection point, which144
corresponds to the foot of the global reflected pressure wave.145
• Reflection Wave Amplitude (RWA) is measured at inflection point in reference146
to the normalized amplitude.147
• Systolic Wave Transit Time (SWTT) is defined as the interval between the148
waveform foot and the systolic peak.149
• Left Ventricular Ejection Time (LVET) is measured by the time interval from the150
foot of the waveform to the dicrotic notch.151
• Augmentation Index (AIx) is computed as the quotient between the reflected152
wave amplitude and the pulse pressure (PP), expressed as a percentage value.153
The equations used for its computation were defined by Murgo, et. al. (1980)154
[31], presented below. A type A waveform is defined when the systolic peak155
occurs in late systole after the inflection point and the type C when the systolic156
peak precedes the inflection point.157
AIx=±SWA−RWA
PP
2.3. Risk Scores Selection158
Four risk scores were considered along this work namely, FRS, PROCAM,159
ASSIGN and SCORE. The FRS was developed from a general population in160
Framingham, Massachusetts, USA, while the remaining scores derive from European161
8
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Figure 2: Arterial pressure waveforms measured non-invasively at carotid artery. In a)
a type A contour is represented , where the peak systolic pressure (SP) occurs in late
systole after an inflection point (Pi) that resulted from the reflection wave. In these
conditions AIx is computed as a positive value. In b) a type C contour is represented.
Notice that in a type C contour the SP precedes the Pi and AIx is computed as a negative
value. The dicrotic wave is represented by DW.
studies. The largest is the SCORE, since it consists of ≈ 205 000 subjects from 12162
cohort studies from European countries. The other two, ASSIGN and PROCAM, were163
developed in Scotland and Germany, respectively. In general, these tools have distinct164
characteristics associated, different risk factors, specific disease, event type, period of165
time and cohort locations. Table 1 summarizes the main characteristics for each one.166
2.4. Statistical Analysis167
The data were analysed using the SPSS 16 statistical package (SPSS Inc.,168
Chicago, Illinois, USA). Descriptive statistics were conducted to describe the sample169
characteristics. The normality results were assessed by the Kolmogorov-Smirnov test.170
To determine the relationships among variables, the Spearman rank-order correlation171
test was used due to the non-normal nature of the distribution. Afterwards, also172
due to the non-normal distribution the Kruskal-Wallis test was conducted to cluster173
comparisons. A p value < 0.05 was considered statistically significant.174
9
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Table 1: Risk assessment tools (10 years term).
Model Patients Country of Origin Risk factors
FRS 8491 USA Age, Gender, Total-CH, CH-
HDL, SBP, BPT, SMK
SCORE 205178 Finland, Russia, Norway,
Denmark, UK (England), UK
(Scotland), Sweden, Belgium,
Germany, Italy, France and
Spain
Age, Gender, Total-CH, CH-
HDL, SBP, and SMK
ASSIGN 13297 Scotland Age, Gender, FH, DB, SMK,
SBP, Total-CH and CH-HDL
PROCAM 5389 Germany Age, CH-LDL, SMK, CH-HDL,
SBP, PE, DB, and TGL
Total-CH − Total Cholesterol, BPT − Blood Pressure Treatment, FH − Family History,
TGL − Triglycerides, SMK − Smoking habits, DB − Diabetes, PE − Previous Event,
SBP − Systolic Blood Pressure, CH-HDL − High-Density Lipoprotein, CH-LDL − Low
Density Lipoprotein.
2.5. Clustering Analysis175
During the cluster assignments, the pulses are independently grouped according176
to their cluster similarities. The adopted strategy for the determination of the ideal177
number of clusters consisted, firstly, in the selection of two clusters (k = 2) followed178
by a tentative to split each of these clusters. During the process, clusters can also be179
merged if they are sufficiently close or, if there is too many patterns and unusually large180
variance.181
The maximum level of similarity for each subject occurs when all pulses fit in only182
one cluster. Expected Maximization (EM) and k-means clustering algorithms are the183
most studied. Weka 3.6.8 framework software was the selected tool to use during the184
cluster analysis (Figure 1(c)).185
2.5.1. k-Means186
The k-means algorithm is a type of partitional clustering that continuously iterates187
until a specific criterion function (usually the square error) converges. It acknowledges188
10
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the number of desired cluster inputs (k) and divides the set of objects (n) into k clusters.189
The result is a higher intra-cluster and lower inter-cluster similarity. The cluster190
similarity is measured considering the mean value of the objects contained in the191
cluster, which is, in fact, the cluster centroid. k-Means clustering is relatively scalable192
and efficient in processing large datasets. However, it cannot handle categorical193
attributes and it is not suitable for dealing with non-convex shapes. Also, it is quite194
sensitive to the presence of noise and outliers. It requires an efficient data pre-195
processing analysis before its application [23].196
2.5.2. Expectation-Maximization197
The Expectation-Maximization (EM) clustering algorithm is a complex198
probabilistic extension of the k-means method that primarily differs by the way how the199
initial groups are obtained. Instead of assigning each object to a cluster, with which it is200
most similar, EM assigns each object to a cluster according to a weight that represents201
the probability of membership. In this manner, there are no strict boundaries between202
clusters, and new means are determined based on weighted measures [23].203
3. Results204
3.1. Subject Characteristics205
The clinical characteristics of our study population are shown in Table 2. The206
mean age of subjects in Group H is 58.10±11.64 years. The blood pressure values207
in this group are elevated (170.98± 11.41 mmHg and 100.29± 9.05 mmHg for SBP208
and DBP, respectively) relatively to normal ranges, 130− 139 mmHg for SBP and209
85− 89 mmHg for DBP [3]. TGL is also a marker of increased risk in this group210
due to be higher than the guideline recommendations (< 150 mg/dL) [3]. The same211
situation is verified for Total-CH values, which are also superior to the guideline212
recommendations (< 190 mg/dL). However, the CH-HDL is within the optimal limits,213
as it is higher than the minimum threshold of 40−45 mg/dL. Finally, it is also possible214
11
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Table 2: Characteristics of subjects
Variable Group H (mean±SD) Group C (mean±SD) Units
Number of subjects 23 93 −
Gender(m/f) 12/11 31/62 −
Age 58.10 ±11.64 21.19±2.28 years
SBP 170.98 ±11.41 108.26±11.88 mmHg
DBP 100.29 ±9.05 69.54±7.64 mmHg
BMI 27.87 ±5.23 21.62±2.63 kg/m2
Total-CH 205.10 ±25.42 − mg/dL
CH-HDL 65.70 ±28.80 − mg/dL
TGL 155.25 ±28.71 − mg/dL
SWTT 224.08 ±52.86 163.45±60.64 ms
RWTT 115.83 ±27.93 159.29 ±43.47 ms
RWA 0.72 ±0.14 0.87±0.09 a.u.a
AIx 25.69 ± 17.14 0.35±15.69 %
LVET 305.40 ±47.46 281.99 ±53.06 ms
SBP - Systolic Blood Pressure, DBP - Diastolic Blood Pressure, BMI - Body Mass Index,
CH-HDL-High Density Lipoprotein Cholesterol, Total-CH - Cholesterol Total, TGL -
Triglycerides, RWTT - Reflected Wave Transit Time, RWA-Reflection Wave Amplitude,
SWTT - Systolic Wave Transit Time, LVET - Left Ventricular Ejection Time, AIx -
Augmentation Index.
a Arbitrary amplitude units
to conclude that the mean Body Mass Index (BMI) in Group H is also superior to the215
ideal recommendations (< 25 kg/m2) [3].216
Regarding Group C, the mean age is 21.19±2.28 years, and the pressure values217
are within normal ranges. Focusing on the APW differences between Group H and218
Group C, SWTT occurs later in the first group, where the arrival time assumes the value219
of 224.08± 52.86 ms, while in Group C, this is at 163.45± 60.64 ms. LVET arrival220
time is quite similar for both groups: 305.40±47.46 ms in Group H and 281.99±53.06221
ms in Group C. The RWTT occurs earlier in Group H (115.83± 27.93ms) at lower222
amplitude (0.72± 0.14), in opposition to the values in Group C (159.29± 43.47 ms,223
at the amplitude of 0.87±0.09). Group H is also characterized by higher positive AIx224
values (25.69±17.14 %), in opposition to the Group C (0.35±15.69 %).225
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3.2. Clustering Analysis226
The cluster analysis was performed for Group C and Group H, independently.227
Different nomenclatures were adopted to help understanding the data at hand, numeric228
labels (1, 2, ...) for the Group C and alphabet labels (A, B, ...) for the Group H. After,229
the cluster analysis, the clusters were compared using the Kruskal-Wallis test.230
3.2.1. Group C231
The first approach consisted in the selection of the best clustering algorithm to deal232
with the set of features at test, as well as the ideal number of clusters to the group233
characterization. Figure 3 displays RWTT and SWTT plot for 2-clusters analysis using234
EM (a) and k-means (b) algorithms. Red and blue coloured points represent the pulse235
labels (blue = Cluster 1, red = Cluster 2). Categorical features (gender, smoker) were236
not considered during the analysis, since k-means analysis is not able to deal with this237
kind attributes.238
The figure shows that the EM plot has an unsatisfactory division between the239
clusters, with some points from Cluster 2 identified as being in the Cluster 1 area.240
Visually, the results from the k-means clustering have a more efficient separation,241
as the dataset is partitioned in two homogeneous risk groups. For both EM and242
k-means, the Cluster 1 represents the pool of healthier subjects when compared to243
the Cluster 2, since it represents the cases where the reflection wave arrives after to244
the systolic peak. The analysis of Cluster 2 also indicates the presence of another245
sub-cluster. Taking this into account, the k-means method was used to explore the246
distribution of a third cluster, since it performed well, comparatively to the EM, in the247
two cluster distribution. The obtained results for a 3 cluster distribution are presented in248
Figure 4. The detailed information about clusters distribution is presented in Table 3.249
The Cluster 3 (green homogeneous zone) is mostly representative of Type C APW250
pulses, where RWTT > SWTT . The mean AIx value of the cluster centroid is negative251
(−11.2 %), thus being considered the lower risk cluster. Cluster 2 predominantly252
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Figure 3: Clusters performance obtained for EM (top) and k-means (bottom)
algorithms using two clusters, Cluster 1=blue, Cluster 2=red.
consists of Type B pulses, with SWTT >RWTT and AIx> 0, being thus considered the253
intermediate risk group. Cluster 1 pulses represents the less homogeneous group, with254
some points also scattered across the Cluster 2 area. These pulses are mainly APW255
Type A pulses, with some punctual Type B pulses. This group evidences a higher256
cardiovascular risk comparatively to the Cluster 2 and Cluster 3.257
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Figure 4: RWTT and SWTT plot after k-means clustering for using three clusters.
Blue=Cluster 1, red=Cluster 2 and Green=Cluster 3.
3.2.2. Group H258
The k-means was also used in the Group H analysis. Figure 5 depicts the 2-cluster259
distribution, where Cluster A and Cluster B were the labels adopted.260
Table 3: Average values for the 3-clusters groups.
Attributes
Cluster
1 2 3
Pulses 458 1550 2463
Age (y) 21.6 21.0 21.7
Weight (kg) 63.0 55.4 63.2
Height (m) 1.7 1.6 1.7
BMI (kg/m2) 21.3 20.8 21.8
SBP (mmHg) 109.9 106.1 108.6
DBP (mmHg) 69.6 70.3 68.9
HR (bpm) 72.8 67.5 72.9
SWTT (ms) 172.7 234.4 117.1
RWTT (ms) 103.0 143.2 179.9
LVET (ms) 240.3 306.4 274.4
SWA (a.u. a) 1.0 1.0 1.0
RWA (a.u. a) 0.8 0.9 0.9
DWA (a.u. a) 0.8 0.8 0.7
AIx (%) 21.0 12.6 -11.2
a Arbitrary Amplitude Units
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Figure 5: Scatter plots for: (a) RWTT and RWA, (b) LVET and SWTT, where the grey
and black markers denote Cluster A and Cluster B, respectively.
The characteristics of each of the clusters are presented in Table 4. It can be verified261
that the clusters do not differ significantly according to the SBP and DBP values. The262
most significant parameters (except APW parameters) were the CH-HDL and the TGL263
Table 4: Cluster distributions for subjects in Group H.
Attributes Cluster A Cluster B
SBP (mmHg) 169.68±10.38 172.56±13.59
DBP (mmHg) 101.22±7.03 102.00±7.14
Total-CH (mg/dL) 206.50±26.16 204.01±13.69
CH-HDL (mg/dL) 59.35±25.07 66.33±23.31
TGL(mg/dL) 160.41±44.95 142.94±40.96
RWTT (ms) 99.90±23.62 140.32±42.76
RWA (a.u. a) 0.60±0.11 0.90±0.06
SWTT (ms) 257.34±35.76 185.34±40.70
LVET (ms) 326.24±39.43 272.16±44.17
AIx (%) 40.01±11.15 6.2±9.67
Clustered instances 723 (52 %) 664 (48 %)
a Arbitrary Amplitude Units
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values. Cluster A is characterized by higher TGL values and lower CH-HDL levels,264
characteristics of subjects at risk. From the waveform analysis, lower RWTT, higher265
SWTT and, consequently, higher positive AIx values were obtained. The suitable266
number of clusters was considered to be two as may be confirmed by visual inspection.267
During the evaluation, the pulse instances were independently grouped according268
to their cluster similarities, being the maximum level of similarity achieved, for each269
subject, when all the pulses fit in a single cluster. So, for each subject a value270
representing the cluster risk (as percentage) was computed and used in the correlation271
with other available parameters (including the studied scores). Since only two clusters272
are studied, at this point, the values of Cluster A (%) are symmetric to the values of273
Cluster B (%). The Cluster A (%) correlations are presented in Table 5.274
The lipidic and the BP values present low significance with the Cluster A (%). On275
the other hand, significant correlation values were obtained between Cluster A (%)276
Table 5: Spearman’s correlation coefficients
obtained for Cluster A (%).
Attributes Cluster A (%)
SBP -0.131
DBP -0.080
Total-CH 0.011
CH-HDL -0.177
TGL 0.017
AIx 0.921 **
SWTT 0.649 **
RWTT -0.632 **
RWA -0.933 **
LVET 0.574 **
FRS 0.458 *
SCORE 0.275
ASSIGN 0.582 **
PROCAM 0.391
Significant levels: ** p< 0.01, *p< 0.05
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and PWA parameters. Additionally, it was obtained a significant correlation between277
Cluster A (%) and the risk scores. In this case was observed a very significant278
correlation with ASSIGN (r = 0.582, p < 0.01), a significant correlation with FRS279
(r = 0.458, p < 0.05) and, weaker correlations with SCORE (r = 0.275, p = 0.241)280
and PROCAM (r= 0.391, p= 0.088). These results are good indicators for the use of281
this methodology as a tool for the cardiovascular risk assessment.282
Figure 6 shows the cluster A (%) distribution (considering a threshold of more than283
50 %) for each of the scores. Targeting data by cluster A (threshold >50%), obtained284
a median risk by the SCORE function of 2.0% per year, FRS function of 13.0% per285
year, ASSIGN function of 16.0% per year and by the PROCAM function of 20.7%286
per year. For the FRS, ASSIGN and PROCAM scores, these values correspond to the287
borderline between high risk and an intermediate risk [32, 33]. However, for SCORE,288
the observed median value corresponds to low risk, being SCORE the less correlated289
Figure 6: Boxplots of CHD risk distribution for SCORE, FRES, ASSIGN and
PROCAM. The horizontal lines represent the medians, the boxes represent the
interquartile ranges (50% of the distribution) and the whiskers represent the range of
values obtained for subjects from GroupH.
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function with the cluster results.290
3.2.3. Comparison of Groups291
The evaluation was performed by the comparison of the clusters in Group H292
(Cluster A and Cluster B) with clusters in Group C (Cluster 1, Cluster 2 and Cluster 3).293
The Cluster A is the cluster at higher risk in the hypertensive groups, as previously294
discussed. Since, there is no medical information about the risk associated to Group C295
(we have only informations concerning the APW parametrizations), each one of296
clusters from Group C was compared to the Group H clusters. The comparison was297
performed using the chi-squared (χ2) value, obtained from the Kruskal-Wallis test, as298
shown in Table 6.299
There are significant differences for the majority of clusters in Group H and300
Group C, as expected due to the distinct population characteristics of each group.301
However, some similarities were found between the Cluster B (the score at lower302
risk in Group H) and the Cluster 1 (belonging to the Group C), namely: for LVET303
(χ2 = 4.79, p< 0.01) and SWTT (χ2 = 0.02, p< 0.01) measures. From the analysis304
of Table 3, it is possible to conclude that this is the cluster at higher risk in Group305
C. However, it is not possible o conclude that the risk associated is effectively risk306
Table 6: Comparison of clusters from Group H (Cluster A and Cluster B) and Group
C (Cluster 1, Cluster 2 and Cluster 3) using Kruskal-Wallis test, measured through χ2
value.
Group H Group C
Parameters
RWTT RWA SWTT RWTT LVET AIx
ClusterA
Cluster1 38.66 ** 402.42** 526.65** 38.66** 369.23** 402.40 **
Cluster2 1149.82** 1399.96 ** 248.87 ** 1149.82** 154.81** 1399.97**
Cluster3 1454.05** 1545.50** 1619.16** 1454.05** 706.65** 1638.37**
ClusterB
Cluster1 536.38 ** 458.25** 0.02 536.38** 4.79 538.34 **
Cluster2 265.77** 3.16 ** 892.34 ** 265.77** 598.03** 49.97 **
Cluster3 593.88** 4.06** 998.62** 593.88** 60.22** 1158.33**
Significant levels: ** p< 0.01
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associated to the development of CVD. This conclusion is only possible from the307
comparison with the clusters of the hypertensive group (Group H). And, the similarities308
are evident for the cluster in analysis (Cluster 1) and the cluster at lower risk in the309
hypertensive group (Cluster B), leading to assume that the subjects belonging to the310
Cluster 1 need medical advice, and that they may be developing CVD. It would not be311
trustable, if the similarities occur for the group of subjects in advanced stage of disease312
(Cluster A). This conclusion supports that is possible to screen a healthy population313
(using only waveform parameters) concerning the cardiovascular risk using clustering314
methodologies.315
4. Discussion316
In this paper a new approach to morphological pulse analysis is presented, and317
an innovative methodology to cardiovascular risk assessment, taking as reference the318
CHD risk scores, is applied.319
The information that is extracted from the clustering analysis can be crucial to fully320
understand of the data, mainly when there is no, or little, available information. It was321
verified, that Total-CH and TGL values are intrinsically related to the APW variables,322
and than an increase of these levels is associated to the RWTT decrease and SWTT323
increase. On the other hand, the higher CH-HDL values are associated to the increase324
of RWTT and decrease of SWTT values. Significant correlations for the cluster output325
with the ASSIGN (r= 0.582, p< 0.01) and with FRS (r= 0.458, p< 0.05) were also326
verified.327
This method is particularly interesting, considering that this approach can avoid the328
requirements of the classification procedures which often require costly labelling of a329
large set of patterns, such as biochemical analysis used by traditional risk scores, as330
demonstrated on the cluster analysis of subjects in Group C. It was possible to identify331
the similarities with Group H clusters, using only morphological parameters. The332
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possibility to emulate the performance of the traditional risk scores by the use of only333
non-invasive parameters, which can be easily obtained using a PWA technique, is an334
efficient alternative approach to study large datasets. In this sense, clustering analysis335
is an easy method for large populations screening producing valuable knowledge for336
posterior prioritising people for pharmacological measures.337
The healthcare public and private system faces the challenge of an increasingly338
aging population and the escalation of medical costs. Therefore, the development of339
techniques that allow for earlier identification of subjects at risk, by the incorporation340
of personalized, predictive and preventive methodologies, could bring an interesting341
impact comparatively to the traditional cardiovascular tools used for risk prediction.342
It is evident the foreseeable impact that an accurate, non-invasive and easy-to-use343
instrument for hemodynamic condition assessment could impart on the diagnosis and344
follow-up of the CVD. However, a similar methodology could be applied to other345
measurements (e. g., invasive pressures, electrocardiogram) used in traditional clinical346
path of cardiovascular patients.347
5. Conclusions348
This paper demonstrates the utility of clustering techniques in risk scoring when349
applied to a medical dataset. When compared with the traditional risk scores, clustering350
methodologies showed good performance with significant correlation values. This is a351
simple, yet reliable tool, that can be used in scoring trials.352
As this approach needs some developments, a computational tool to integrate these353
results with other machine learning techniques such as classification algorithms, is354
currently being developed [15]. A larger sample will also be studied in future trials355
for the stratification by medication use, age, diabetes duration, and/or gender. Given356
these considerations, this application can be an interesting methodology to be used357
in further clinical studies to pulse morphological analysis. It can also be potentially358
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useful in other medical applications, such as in the anaesthesiology room, where the359
number of parameters and devices are high, as a tool that incorporates several important360
information.361
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